Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Products & comparisons
Product source

Liposomal NMN + NR by GenuinePurity: DSLD Label Record 336118

A US dietary supplement label record lists Liposomal NMN + NR from GenuinePurity as capsules with 250 mg beta-nicotinamide mononucleotide and 250 mg nicotinamide riboside per labelled serving. The database entry documents label declarations only, not efficacy, safety or approval. [1]

Automatic summary · not editorially reviewed

Label · NIH DSLD
Liposomal NMN + NROriginal label · NIH DSLD
Liposomal NMN + NR

FROM THE ORIGINAL LABEL

A closer look at the product

Pack contents
60 Capsule(s)
Label serving
2 VCapsule(s)
Servings per container
30
Barcode / SKU
6 28043 00145 9
Open original label (PDF)
Ingredients & declared amounts2

Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.

IngredientAmountPer label serving
Beta-Nicotinamide Mononucleotide250 mg2 VCapsule(s)
Nicotinamide Riboside250 mg2 VCapsule(s)

Other ingredients: Cellulose, Microcrystalline Cellulose, Maltodextrin, Sunflower Lecithin, Phosphatidylcholine, Silicon Dioxide, Stearate

Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.

The key findings

  1. DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]

  2. The label declares beta-nicotinamide mononucleotide at 250 mg and nicotinamide riboside at 250 mg per labelled serving. [1]

  3. The record is a snapshot of label declarations only and supplies no independent testing, price or batch certificate. [1]

The source at a glance

Brand
GenuinePurity
Form
Capsule
Pack contents
60 Capsule(s)
Label serving
2 VCapsule(s)
Ingredients listed
Beta-Nicotinamide Mononucleotide · Nicotinamide Riboside
Record type / format
Product label/database record (DSLD entry 336118); not a study.
Scope / context
The described product: Liposomal NMN + NR capsules by GenuinePurity, not a patient population.
Summary based on
Product label / database record

DSLD record 336118 for the GenuinePurity product

This is a record in the NIH Dietary Supplement Label Database (DSLD), entry 336118. The product label name is Liposomal NMN + NR, the declared brand is GenuinePurity, and the label lists the physical form as capsule. DSLD files it under the product category 'Other Combinations'. The record notes that the label entered DSLD on 2025-08-22; this is a database entry date, not a product launch date. The record describes label declarations only.

Supporting source [1]

Declared ingredients and amounts per labelled serving

The label declares two ingredients with amounts: beta-nicotinamide mononucleotide at 250 mg per labelled serving and nicotinamide riboside at 250 mg per labelled serving. These are label facts as recorded in the database. They are not a recommendation for a serving, dose or use, and the record gives no personal dosing advice. The record does not state how many capsules make up a labelled serving.

Supporting source [1]

What this database listing does not establish

Inclusion in DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record supplies no independent product testing, no price and no batch certificate. It is a snapshot of label declarations, so it cannot show whether the product works or is approved.

Supporting source [1]

How to interpret this

Product label record; not evidence of efficacy or approval. Abstract-level database snapshot only; no independent testing, price, batch certificate or retail availability is supplied.

Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.

Source & supporting passages

[1]
Liposomal NMN + NR

GenuinePurity · dsld.od.nih.gov

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    DSLD inclusion does not establish efficacy, safety,
  2. Finding 2 ↑

    Beta-Nicotinamide Mononucleotide: 250 mg per labelled serving
  3. Finding 3 ↑

    This snapshot describes label declarations only

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…